Captario

Founded in 2012 by four pharmaceutical industry veterans, Captario is a specialized software-as-a-service (SaaS) company focused on the pharmaceutical sector. The company's genesis lies in the founders' firsthand experience with the inefficiencies and siloed nature of decision-making within large pharma, particularly concerning the lengthy drug development lifecycle. One of the co-founders, Johannes Vänngård, who now serves as CEO, previously spent five years as an independent consultant assisting major pharmaceutical companies in refining their decision-making processes. This collective experience, totaling over 200 years in the pharmaceutical space, spurred the creation of a solution to a problem they intimately understood.

Captario's core offering is Captario SUM® (Strategic Uncertainty Management), a cloud-based modeling and simulation platform. This tool is designed to support strategic decisions throughout the entire drug development and commercialization process, from clinical trials to market launch. The platform addresses the inherent uncertainties in drug development by utilizing multi-dimensional Monte Carlo simulations, artificial intelligence, and machine learning to model a vast range of potential future scenarios. This allows project and portfolio teams to analyze trade-offs between time, cost, risk, and value. A key feature is the ability for real-time data updates across departments, which helps to break down information silos and enables more dynamic and holistic analysis of opportunities and portfolios. The software also includes a sandbox environment where clients can run 'what-if' scenarios without altering their primary data.

The company's business model is centered on subscriptions to its Captario SUM® platform. In late 2022, Captario expanded its revenue streams by launching Professional Services, which can be engaged either in conjunction with a software subscription or as a standalone service to address specific, complex development questions. Captario's clientele primarily consists of pharmaceutical organizations, and the company reports that it supports one-third of the top 30 global pharmaceutical companies. Headquartered in Gothenburg, Sweden, Captario has a global presence with offices in New York, Basel, Cluj, and Adelaide.

Keywords: pharmaceutical R&D, strategic decision support, drug development simulation, portfolio management software, Monte Carlo simulation, clinical trial modeling, pharmaceutical commercialization, Johannes Vänngård, Strategic Uncertainty Management, life science analytics, pharma decision-making, drug portfolio optimization, R&D cost analysis, risk mitigation in pharma, end-to-end drug development, pharma SaaS, Gothenburg startups, clinical to commercial, what-if scenario analysis, pharma project management